Oruka Therapeutics (ORKA) Profit After Tax Growth (5y) (2015 - 2024)
Oruka Therapeutics (ORKA) Profit After Tax Growth (5y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Oruka Therapeutics | 949.58 Mn | 118.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -13.27% |
| Mar 31, 2024 | -3.84% |
| Dec 31, 2023 | 6.07% |
| Sep 30, 2023 | 2.22% |
| Jun 30, 2023 | 6.90% |
| Mar 31, 2023 | 13.22% |
| Dec 31, 2022 | 22.49% |
| Sep 30, 2022 | 12.04% |
| Jun 30, 2022 | 10.64% |
| Mar 31, 2022 | 5.48% |
| Dec 31, 2021 | -6.02% |
| Sep 30, 2021 | -0.23% |
| Jun 30, 2021 | -4.46% |
| Mar 31, 2021 | -2.40% |
| Dec 31, 2020 | -10.10% |
| Sep 30, 2020 | 6.69% |
| Jun 30, 2020 | 13.69% |
| Mar 31, 2020 | 13.62% |
| Dec 31, 2019 | 14.03% |
| Sep 30, 2019 | 12.73% |